ArriVent BioPharma

ArriVent Reports Promising Results for Firmonertinib in Lung Cancer Patients With Rare EGFR Mutations

NEWTOWN SQUARE, PA – ArriVent BioPharma, Inc. (Nasdaq: AVBP) presented final proof-of-concept results from its global Phase 1b FURTHER trial of firmonertinib, an oral targeted therapy for patients with non-small …

ArriVent Reports Promising Results for Firmonertinib in Lung Cancer Patients With Rare EGFR Mutations Read More



Lincoln Financial

Lincoln Financial Expands Fixed Indexed Annuity Options With New Growth and Diversification Strategies

RADNOR, PA — Lincoln Financial Group (NYSE: LNC) announced enhancements to its fixed indexed annuities (FIAs), introducing new investment options aimed at offering investors greater growth potential and diversification while …

Lincoln Financial Expands Fixed Indexed Annuity Options With New Growth and Diversification Strategies Read More